Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.85 |
Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.26 |
NCAM signaling for neurite out-growth | R-HSA-375165 | 4.9 |
Platelet degranulation | R-HSA-114608 | 6.68 |
Signaling by Interleukins | R-HSA-449147 | 4.71 |
Signaling by Leptin | R-HSA-2586552 | 5.1 |
Frs2-mediated activation | R-HSA-170968 | 5.12 |
MAP2K and MAPK activation | R-HSA-5674135 | 7.66 |
Cytokine Signaling in Immune system | R-HSA-1280215 | 3.74 |
Extracellular matrix organization | R-HSA-1474244 | 4.91 |
IGF1R signaling cascade | R-HSA-2428924 | 4.85 |
Downstream signal transduction | R-HSA-186763 | 4.65 |
IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.85 |
Signaling by ERBB4 | R-HSA-1236394 | 4.7 |
Innate Immune System | R-HSA-168249 | 3.17 |
IRS-mediated signalling | R-HSA-112399 | 4.87 |
MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.11 |
Disease | R-HSA-1643685 | 3.33 |
RAF/MAP kinase cascade | R-HSA-5673001 | 5.15 |
Integrin cell surface interactions | R-HSA-216083 | 6.57 |
Platelet Aggregation (Plug Formation) | R-HSA-76009 | 7.77 |
Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.71 |
MAPK family signaling cascades | R-HSA-5683057 | 4.89 |
Signalling by NGF | R-HSA-166520 | 4.23 |
Signaling by VEGF | R-HSA-194138 | 4.66 |
Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.12 |
Platelet activation, signaling and aggregation | R-HSA-76002 | 5.15 |
FCERI mediated MAPK activation | R-HSA-2871796 | 4.32 |
Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 6.59 |
Signaling by EGFR | R-HSA-177929 | 4.59 |
p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 9.08 |
FRS-mediated FGFR2 signaling | R-HSA-5654700 | 5.14 |
SOS-mediated signalling | R-HSA-112412 | 5.15 |
FRS-mediated FGFR3 signaling | R-HSA-5654706 | 5.14 |
Developmental Biology | R-HSA-1266738 | 3.48 |
Amyloids | R-HSA-977225 | 7.37 |
Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.71 |
Insulin receptor signalling cascade | R-HSA-74751 | 4.85 |
Signaling by FGFR4 | R-HSA-5654743 | 4.69 |
Signaling by FGFR3 | R-HSA-5654741 | 4.69 |
VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.7 |
GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.15 |
Interleukin receptor SHC signaling | R-HSA-912526 | 5.09 |
Signaling by FGFR | R-HSA-190236 | 4.67 |
Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.03 |
Immune System | R-HSA-168256 | 2.37 |
Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.71 |
FRS-mediated FGFR4 signaling | R-HSA-5654712 | 5.14 |
Signaling by SCF-KIT | R-HSA-1433557 | 4.73 |
Interleukin-2 signaling | R-HSA-451927 | 5.05 |
SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.15 |
Signaling by ERBB2 | R-HSA-1227986 | 4.66 |
Signalling to RAS | R-HSA-167044 | 5.08 |
DAP12 signaling | R-HSA-2424491 | 4.64 |
Interleukin-3, 5 and GM-CSF signaling | R-HSA-512988 | 4.99 |
Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.71 |
Signaling by FGFR1 | R-HSA-5654736 | 4.69 |
SHC1 events in EGFR signaling | R-HSA-180336 | 5.15 |
NGF signalling via TRKA from the plasma membrane | R-HSA-187037 | 4.51 |
FRS-mediated FGFR1 signaling | R-HSA-5654693 | 5.14 |
Prolonged ERK activation events | R-HSA-169893 | 5.11 |
Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 7.7 |
Signaling by GPCR | R-HSA-372790 | 2.68 |
Signaling by FGFR2 | R-HSA-5654738 | 4.68 |
GRB2 events in EGFR signaling | R-HSA-179812 | 5.15 |
Signalling to ERKs | R-HSA-187687 | 5.04 |
Signaling by Insulin receptor | R-HSA-74752 | 4.73 |
Integrin alphaIIb beta3 signaling | R-HSA-354192 | 8.23 |
ARMS-mediated activation | R-HSA-170984 | 5.12 |
GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 9.08 |
DAP12 interactions | R-HSA-2172127 | 4.56 |
SHC1 events in ERBB4 signaling | R-HSA-1250347 | 5.15 |
Signaling by PDGF | R-HSA-186797 | 4.53 |
Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.52 |
Axon guidance | R-HSA-422475 | 3.93 |
VEGFR2 mediated cell proliferation | R-HSA-5218921 | 5.07 |
Hemostasis | R-HSA-109582 | 3.98 |
Signal Transduction | R-HSA-162582 | 1.78 |